Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Le Houezec

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Tobacco Control|June 1, 2005
France: smoking in pregnancy consensus conferenceJacques Le Houezec
Clinical Pharmacology and Therapeutics|December 3, 2005
Why a nicotine vaccine?Jacques Le Houezec
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|May 25, 2002
Advances in neuroscience and pharmacology of nicotine. 3rd SRNT Europe Conference, Paris, France, 19-22 September 2001David Balfour, Jacques Le Houezec
Journal of Pharmacy & Bioallied Sciences|February 21, 2017
Electronic cigarette experimentation in the Malaysian city of Kuantan: Was there an association with the smoking status?Konstantinos E Farsalinos, Jacques Le Houezec
Expert Opinion on Pharmacotherapy|August 28, 2013
Pharmacotherapies and harm-reduction options for the treatment of tobacco dependenceJacques Le Houezec, Henri-Jean Aubin
Risk Management and Healthcare Policy|October 13, 2015
Regulation in the face of uncertainty: the evidence on electronic nicotine delivery systems (e-cigarettes)Konstantinos E Farsalinos, Jacques Le Houezec
Obstetrics and Gynecology|May 2, 2006
Smoking habits, nicotine use, and congenital malformationsJacques Le Houezec, Neal L Benowitz
Drug and Alcohol Review|March 8, 2011
Tobacco, nicotine and harm reductionJacques Le Houezec, Ann McNeill, John Britton
Tobacco Control|August 4, 2006
Time for a tobacco and nicotine regulatory authority for FranceJacques Le Houezec, Albert Hirsch, Yves Martinet
Seminars in Thrombosis and Hemostasis|May 8, 2014
Comment on "E-cigarettes and cardiovascular risk: beyond science and mysticism"Konstantinos E Farsalinos, Giorgio Romagna, Jacques Le Houezec
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Tobacco Control|June 1, 2005
France: smoking in pregnancy consensus conferenceJacques Le Houezec
Clinical Pharmacology and Therapeutics|December 3, 2005
Why a nicotine vaccine?Jacques Le Houezec
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|May 25, 2002
Advances in neuroscience and pharmacology of nicotine. 3rd SRNT Europe Conference, Paris, France, 19-22 September 2001David Balfour, Jacques Le Houezec
Journal of Pharmacy & Bioallied Sciences|February 21, 2017
Electronic cigarette experimentation in the Malaysian city of Kuantan: Was there an association with the smoking status?Konstantinos E Farsalinos, Jacques Le Houezec
Expert Opinion on Pharmacotherapy|August 28, 2013
Pharmacotherapies and harm-reduction options for the treatment of tobacco dependenceJacques Le Houezec, Henri-Jean Aubin
Risk Management and Healthcare Policy|October 13, 2015
Regulation in the face of uncertainty: the evidence on electronic nicotine delivery systems (e-cigarettes)Konstantinos E Farsalinos, Jacques Le Houezec
Obstetrics and Gynecology|May 2, 2006
Smoking habits, nicotine use, and congenital malformationsJacques Le Houezec, Neal L Benowitz
Drug and Alcohol Review|March 8, 2011
Tobacco, nicotine and harm reductionJacques Le Houezec, Ann McNeill, John Britton
Tobacco Control|August 4, 2006
Time for a tobacco and nicotine regulatory authority for FranceJacques Le Houezec, Albert Hirsch, Yves Martinet
Seminars in Thrombosis and Hemostasis|May 8, 2014
Comment on "E-cigarettes and cardiovascular risk: beyond science and mysticism"Konstantinos E Farsalinos, Giorgio Romagna, Jacques Le Houezec
Pageof 3